Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routine.
about
Evaluation of the Abbott Investigational Use Only RealTime Hepatitis C Virus (HCV) Assay and Comparison to the Roche TaqMan HCV Analyte-Specific Reagent AssayEvaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test and identification of rare polymorphisms potentially affecting assay performanceAnalytical Performances of Human Immunodeficiency Virus Type 1 RNA-Based Amplix® Real-Time PCR Platform for HIV-1 RNA QuantificationPlasma interleukin-27 (IL-27) levels are not modulated in patients with chronic HIV-1 infectionComparative evaluation of the performance of the Abbott RealTime HIV-1 assay for measurement of HIV-1 plasma viral load on genetically diverse samples from GreeceSystematic review of the performance of HIV viral load technologies on plasma samples.Evaluation of Performance Characteristics of the Aptima HIV-1 Quant Dx Assay for Detection and Quantitation of Human Immunodeficiency Virus Type 1 in Plasma and Cervicovaginal Lavage Samples.HIV-2 diagnosis and quantification in high-risk patients.Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes.Comparison of the Abbott Realtime HIV-1 and HCV viral load assays with commercial competitor assays.Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENEvaluation of the Abbott investigational use only realtime HIV-1 assay and comparison to the Roche Amplicor HIV-1 monitor test, version 1.5.Evaluation of the Cavidi ExaVir Load assay (version 3) for plasma human immunodeficiency virus type 1 load monitoring.Analytical characteristics and comparative evaluation of Aptima HIV-1 Quant Dx assay with Ampliprep/COBAS TaqMan HIV-1 test v2.0.Current challenges to viral load testing in the context of emerging genetic diversity of HIV-1.Upgraded Cobas Ampliprep-Cobas TaqMan version 2.0 HIV-1 RNA quantification assay versus first version: correction of underestimations.Performance of three commercial viral load assays, Versant human immunodeficiency virus type 1 (HIV-1) RNA bDNA v3.0, Cobas AmpliPrep/Cobas TaqMan HIV-1, and NucliSens HIV-1 EasyQ v1.2, testing HIV-1 non-B subtypes and recombinant variants.Unclear results in the article by Wolff and Gerritzen in Clin Chem Lab Med 2007;45(7):917-922.Comparison of the Abbott realtime human immunodeficiency virus type 1 (HIV-1) assay to the Cobas AmpliPrep/Cobas TaqMan HIV-1 test: workflow, reliability, and direct costs.Development of candidate reference reagent for HIV-1 RNA and comparison analysis for different HIV-1 RNA quantitative assay.Factors contributing to salivary human immunodeficiency virus type-1 levels measured by a Poisson distribution-based PCR method.First field evaluation of the optimized CE marked Abbott protocol for HIV RNA testing on dried blood spot in a routine clinical setting in Vietnam.
P2860
Q27489512-464268BD-4739-496B-B194-081112CD5E94Q28286100-C87ED2FE-D5DB-4737-80B3-72B8A75B7E9EQ28354038-67A52235-E0D6-467B-A2AA-EEEB036BD8C9Q33712080-A9485FC0-C6BC-4D31-9AC5-55429D650CBFQ34547246-87A498B6-F55F-48E7-A6A8-A7BA8BF91EFBQ35099443-665D8E1B-26DC-4C86-8112-D5FD4666A9ACQ36734872-934AB535-8D5B-425D-A6B5-940BD5578F23Q36862541-0A043CEF-9AAF-4121-A2F7-8403C1138734Q37191559-DCDEB967-7019-4B27-94AD-5B2A7D73CD98Q37206232-19469CFB-F77F-4ECB-BB87-962AFC987CD1Q37256264-E1C75485-9CE8-40B6-93EB-BCE2C3A23559Q37261877-7581A620-A061-4AF5-98D8-805B69BF8FC9Q37333664-2FC177FF-1294-42DC-9326-154B8F9D1DDEQ37356705-531B4090-1696-43CE-92AD-8C0E4E3B1385Q38088726-6E379F85-B7BB-465D-9A14-1BB07A3D08F3Q41844856-7591044E-3528-48C0-AB7C-91D63AFE8DBDQ41961412-D41FD6F0-FCB6-4BC4-866B-BD724F3BB912Q43046648-2C1C4B9D-28B2-4361-B217-BA1B48485BE1Q43146564-116DA420-9618-4033-9384-9E69DBE3517DQ44948112-2EACAC4F-E5F5-4D92-97A7-1EF0DA8FFF03Q45325083-86066D61-7B1F-4328-BFFC-9C890F5306A4Q50099405-2A0EE61F-BBDB-4B1F-8757-EB7A68EAA5B6
P2860
Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routine.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Comparison of four commercial ...... ing in clinical daily routine.
@en
Comparison of four commercial ...... ing in clinical daily routine.
@nl
type
label
Comparison of four commercial ...... ing in clinical daily routine.
@en
Comparison of four commercial ...... ing in clinical daily routine.
@nl
prefLabel
Comparison of four commercial ...... ing in clinical daily routine.
@en
Comparison of four commercial ...... ing in clinical daily routine.
@nl
P2093
P2860
P356
P1476
Comparison of four commercial ...... ing in clinical daily routine.
@en
P2093
Frank Wiesmann
Frauke Zabbai
Gerald Warnat
Heribert Knechten
Mechthild Knickmann
Patrick Braun
Rainer Kühn
Robert Ehret
Sven Thamm
P2860
P356
10.1515/CCLM.2007.008
P577
2007-01-01T00:00:00Z